161 related articles for article (PubMed ID: 12398786)
21. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety.
Wiedermann CJ; Hoffmann JN; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Keinecke HO; Warren BL; Opal SM;
Crit Care Med; 2006 Feb; 34(2):285-92. PubMed ID: 16424704
[TBL] [Abstract][Full Text] [Related]
22. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
Lee WL; Downey GP
Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
[TBL] [Abstract][Full Text] [Related]
23. [Antithrombin III in the treatment of disseminated intravascular coagulation].
Nordgaard-Andersen I; Madsen JR
Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
[No Abstract] [Full Text] [Related]
24. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
Emerson TE; Fournel MA; Redens TB; Taylor FB
Am J Med; 1989 Sep; 87(3B):27S-33S. PubMed ID: 2679067
[TBL] [Abstract][Full Text] [Related]
25. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
Gårdlund B
Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
[TBL] [Abstract][Full Text] [Related]
26. Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis.
Allingstrup M; Wetterslev J; Ravn FB; Møller AM; Afshari A
Intensive Care Med; 2016 Apr; 42(4):505-520. PubMed ID: 26862016
[TBL] [Abstract][Full Text] [Related]
27. [Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders].
Ribeiro AA; Lourenço DM; Toledo CF; Noguti MA; Borges DR
Rev Assoc Med Bras (1992); 1997; 43(3):189-94. PubMed ID: 9497544
[TBL] [Abstract][Full Text] [Related]
28. A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Haire WD; Ruby EI; Stephens LC; Reed E; Tarantolo SR; Pavletic ZS; Bierman PJ; Bishop M; Kessinger A; Vose J; Armitage JO
Biol Blood Marrow Transplant; 1998; 4(3):142-50. PubMed ID: 9923412
[TBL] [Abstract][Full Text] [Related]
29. Epilogue: disseminated intravascular coagulation and antithrombin III in intensive care medicine: pathophysiological insights and therapeutic hopes.
Schuster HP
Semin Thromb Hemost; 1998; 24(1):81-3. PubMed ID: 9515783
[No Abstract] [Full Text] [Related]
30. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis.
Eisele B; Lamy M; Thijs LG; Keinecke HO; Schuster HP; Matthias FR; Fourrier F; Heinrichs H; Delvos U
Intensive Care Med; 1998 Jul; 24(7):663-72. PubMed ID: 9722035
[TBL] [Abstract][Full Text] [Related]
31. Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
Hayakawa M; Yamakawa K; Kudo D; Ono K
Clin Appl Thromb Hemost; 2018 Sep; 24(6):874-883. PubMed ID: 29514467
[TBL] [Abstract][Full Text] [Related]
32. Antithrombin (AT) substitution: sense or nonsense?
Köhler M
Anaesthesia; 1998 May; 53 Suppl 2():52-4. PubMed ID: 9659067
[No Abstract] [Full Text] [Related]
33. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients.
Koami H; Sakamoto Y; Sakurai R; Ohta M; Imahase H; Yahata M; Umeka M; Miike T; Nagashima F; Iwamura T; Yamada KC; Inoue S
Thromb Res; 2017 Sep; 157():84-89. PubMed ID: 28711778
[TBL] [Abstract][Full Text] [Related]
35. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
[TBL] [Abstract][Full Text] [Related]
36. The anti-inflammatory properties of antithrombin III: new therapeutic implications.
Okajima K; Uchiba M
Semin Thromb Hemost; 1998; 24(1):27-32. PubMed ID: 9515777
[TBL] [Abstract][Full Text] [Related]
37. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
38. Protein C substitution in sepsis-associated purpura fulminans.
Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
[TBL] [Abstract][Full Text] [Related]
39. Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock.
Fourrier F; Jourdain M; Tournoys A; Gosset P; Mangalaboyi J; Chopin C
Shock; 1998 Nov; 10(5):364-70. PubMed ID: 9840653
[TBL] [Abstract][Full Text] [Related]
40. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
